Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 579

1.

Increased HLA-G Expression in Term Placenta of Women with a History of Recurrent Miscarriage Despite Their Genetic Predisposition to Decreased HLA-G Levels.

Craenmehr MHC, Nederlof I, Cao M, Drabbels JJM, Spruyt-Gerritse MJ, Anholts JDH, Kapsenberg HM, Stegehuis JA, van der Keur C, Fasse E, Haasnoot GW, van der Hoorn MP, Claas FHJ, Heidt S, Eikmans M.

Int J Mol Sci. 2019 Feb 1;20(3). pii: E625. doi: 10.3390/ijms20030625.

2.

Presence of intragraft B cells during acute renal allograft rejection is accompanied by changes in peripheral blood B cell subsets.

Heidt S, Vergunst M, Anholts JDH, Swings GMJS, Gielis EMJ, Groeneweg KE, Witkamp MJ, de Fijter JW, Reinders MEJ, Roelen DL, Eikmans M, Claas FHJ.

Clin Exp Immunol. 2019 Feb 3. doi: 10.1111/cei.13269. [Epub ahead of print]

PMID:
30712266
3.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

4.

Jon van Rood: The pioneer and his personal view on the early developments of HLA and immunogenetics.

Jager MJ, Brand A, Claas FHJ.

Transpl Immunol. 2019 Feb;52:1-26. doi: 10.1016/j.trim.2018.12.006. Epub 2019 Jan 4. Review.

5.

Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome.

van der Zwan A, van der Meer-Prins EMW, van Miert PPMC, van den Heuvel H, Anholts JDH, Roelen DL, Claas FHJ, Heidt S.

Front Immunol. 2018 Dec 6;9:2880. doi: 10.3389/fimmu.2018.02880. eCollection 2018.

6.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
7.

Prolongation of allograft survival by passenger donor regulatory T cells.

Harper IG, Gjorgjimajkoska O, Siu JHY, Parmar J, Mulder A, Claas FHJ, Hosgood SA, Nicholson ML, Motallebzadeh R, Pettigrew GJ.

Am J Transplant. 2018 Dec 12. doi: 10.1111/ajt.15212. [Epub ahead of print]

PMID:
30548563
8.

An Easy and Sensitive Method to Profile the Antibody Specificities of HLA-Specific Memory B Cells.

Karahan GE, Krop J, Wehmeier C, de Vaal Y, Langerak-Langerak J, Roelen DL, Lardy NM, Bemelman FJ, Ten Berge I, Reinders MEJ, van Kooten C, Claas FHJ, Heidt S.

Transplantation. 2018 Nov 9. doi: 10.1097/TP.0000000000002516. [Epub ahead of print]

PMID:
30418423
9.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2018 Oct 25. doi: 10.1093/ndt/gfy316. [Epub ahead of print]

PMID:
30365008
10.

No Evidence for Cross-reactivity of Virus-specific Antibodies With HLA Alloantigens.

Heidt S, Feltkamp MC, Karahan GE, de Brouwer CS, Langerak-Langerak J, Mulder A, Claas FHJ.

Transplantation. 2018 Nov;102(11):1844-1849. doi: 10.1097/TP.0000000000002369.

PMID:
30346375
11.

The long and winding road towards epitope matching in clinical transplantation.

Kramer CSM, Israeli M, Mulder A, Doxiadis IIN, Haasnoot GW, Heidt S, Claas FHJ.

Transpl Int. 2019 Jan;32(1):16-24. doi: 10.1111/tri.13362. Epub 2018 Nov 26. Review.

PMID:
30341790
12.

Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.

Rijkers M, Schmidt D, Lu N, Kramer CSM, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Leebeek FWG, Jansen AJG, Jongerius I, Zeerleder SS, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2019 Feb;104(2):403-416. doi: 10.3324/haematol.2018.201665. Epub 2018 Sep 27.

13.

Exposure to non-inherited maternal antigens by breastfeeding affects antibody responsiveness.

Schonewille H, van Rood JJ, Verduin EP, van de Watering LMG, Haasnoot GW, Claas FHJ, Oepkes D, Lopriore E, Brand A.

Haematologica. 2019 Feb;104(2):263-268. doi: 10.3324/haematol.2018.199406. Epub 2018 Sep 13.

14.

Toward a sensible single antigen bead cut-off based on kidney graft survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy JNM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2018 Aug 13. doi: 10.1097/TP.0000000000002357. [Epub ahead of print]

PMID:
30106794
15.

Technical challenges and clinical relevance of single antigen bead C1q/C3d testing and IgG subclass analysis of human leukocyte antigen antibodies.

Karahan GE, Claas FHJ, Heidt S.

Transpl Int. 2018 Nov;31(11):1189-1197. doi: 10.1111/tri.13327. Epub 2018 Aug 24. Review.

PMID:
30091231
16.

The combination of maternal KIR-B and fetal HLA-C2 is associated with decidua basalis acute atherosis in pregnancies with preeclampsia.

Johnsen GM, Størvold GL, Drabbels JJM, Haasnoot GW, Eikmans M, Spruyt-Gerritse MJ, Alnæs-Katjavivi P, Scherjon SA, Redman CWG, Claas FHJ, Staff AC.

J Reprod Immunol. 2018 Sep;129:23-29. doi: 10.1016/j.jri.2018.07.005. Epub 2018 Jul 25.

PMID:
30055414
17.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

PMID:
30049681
18.

Reduced Risk of BK Polyomavirus Infection in HLA-B51 Positive Kidney Transplant Recipients.

Wunderink HF, Haasnoot GW, de Brouwer CS, van Zwet EW, Kroes ACM, de Fijter JW, Rotmans JI, Claas FHJ, Feltkamp MCW.

Transplantation. 2018 Jul 25. doi: 10.1097/TP.0000000000002376. [Epub ahead of print]

PMID:
30048396
19.

No evidence for cross-reactivity of virus-specific antibodies with HLA allo-antigens.

Heidt S, Feltkamp MC, Karahan GE, de Brouwer CS, Langerak-Langerak J, Mulder A, Claas FH.

Transplantation. 2018 Jul 13. doi: 10.1097/TP.0000000000002369. [Epub ahead of print]

PMID:
30015700
20.

Transplantation in highly sensitized patients: challenges and recommendations.

Heidt S, Claas FHJ.

Expert Rev Clin Immunol. 2018 Aug;14(8):673-679. doi: 10.1080/1744666X.2018.1498335. Epub 2018 Jul 13.

PMID:
30004800
21.

Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells.

Yang J, Anholts J, Kolbe U, Stegehuis-Kamp JA, Claas FHJ, Eikmans M.

Int J Mol Sci. 2018 Jun 21;19(7). pii: E1833. doi: 10.3390/ijms19071833.

22.

A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation.

Rijkers M, Saris A, Heidt S, Mulder A, Porcelijn L, Claas FHJ, Bierings R, Leebeek FWG, Jansen AJG, Vidarsson G, Voorberg J, de Haas M.

Haematologica. 2018 Oct;103(10):1741-1752. doi: 10.3324/haematol.2018.189365. Epub 2018 Jun 1.

23.

How the definition of acceptable antigens and epitope analysis can facilitate transplantation of highly sensitized patients with excellent long-term graft survival.

Heidt S, Haasnoot GW, Claas FHJ.

Curr Opin Organ Transplant. 2018 Aug;23(4):493-499. doi: 10.1097/MOT.0000000000000545.

PMID:
29846197
24.

Genome-wide association studies in kidney transplantation: Advantages and constraints.

Yang J, Claas FHJ, Eikmans M.

Transpl Immunol. 2018 Aug;49:1-4. doi: 10.1016/j.trim.2018.04.004. Epub 2018 Apr 25.

PMID:
29704558
25.

Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.

Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P.

Am J Transplant. 2018 Jul;18(7):1604-1614. doi: 10.1111/ajt.14752. Epub 2018 May 22.

PMID:
29603613
26.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

27.

Human Cytomegalovirus Infection Increases Both Antibody- and Non-Antibody-Dependent Cellular Reactivity by Natural Killer Cells.

Michelo CM, van Cranenbroek B, Touw P, Claas FHJ, van der Meer A, Joosten I.

Transplant Direct. 2017 Nov 20;3(12):e335. doi: 10.1097/TXD.0000000000000750. eCollection 2017 Dec.

28.

Lower frequency of the HLA-G UTR-4 haplotype in women with unexplained recurrent miscarriage.

Meuleman T, Drabbels J, van Lith JMM, Dekkers OM, Rozemuller E, Cretu-Stancu M, Claas FHJ, Bloemenkamp KWM, Eikmans M.

J Reprod Immunol. 2018 Apr;126:46-52. doi: 10.1016/j.jri.2018.02.002. Epub 2018 Feb 7.

PMID:
29481987
29.

Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.

Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Vossen ACTM.

J Reprod Immunol. 2018 Apr;126:39-45. doi: 10.1016/j.jri.2018.01.002. Epub 2018 Jan 31.

30.

Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome.

Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M.

Transpl Immunol. 2018 Jun;48:39-46. doi: 10.1016/j.trim.2018.02.009. Epub 2018 Feb 20.

PMID:
29475090
31.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

32.

HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.

Cao J, Brouwer NJ, Jordanova ES, Marinkovic M, van Duinen SG, de Waard NE, Ksander BR, Mulder A, Claas FHJ, Heemskerk MHM, Jager MJ.

Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):1005-1015. doi: 10.1167/iovs.17-23209.

PMID:
29450544
33.

Human and Rhesus Macaque KIR Haplotypes Defined by Their Transcriptomes.

Bruijnesteijn J, van der Wiel MKH, Swelsen WTN, Otting N, de Vos-Rouweler AJM, Elferink D, Doxiadis GG, Claas FHJ, Lardy NM, de Groot NG, Bontrop RE.

J Immunol. 2018 Mar 1;200(5):1692-1701. doi: 10.4049/jimmunol.1701480. Epub 2018 Jan 22.

PMID:
29358278
34.

Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome.

Rovito R, Claas FHJ, Haasnoot GW, Roelen DL, Kroes ACM, Eikmans M, Vossen ACTM.

Front Immunol. 2018 Jan 5;8:1904. doi: 10.3389/fimmu.2017.01904. eCollection 2017.

35.

Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity.

van der Zwan A, Bi K, Norwitz ER, Crespo ÂC, Claas FHJ, Strominger JL, Tilburgs T.

Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):385-390. doi: 10.1073/pnas.1713957115. Epub 2017 Dec 19.

36.

Paternal HLA-C is a risk factor in unexplained recurrent miscarriage.

Meuleman T, Haasnoot GW, van Lith JMM, Verduijn W, Bloemenkamp KWM, Claas FHJ.

Am J Reprod Immunol. 2018 Feb;79(2). doi: 10.1111/aji.12797. Epub 2017 Dec 4.

PMID:
29205643
37.

Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Meysman P, De Neuter N, Bartholomeus E, Elias G, Van den Bergh J, Emonds MP, Haasnoot GW, Heynderickx S, Wens J, Michels NR, Lambert J, Lion E, Claas FHJ, Goossens H, Smits E, Van Damme P, Van Tendeloo V, Beutels P, Suls A, Mortier G, Laukens K, Ogunjimi B.

Immunogenetics. 2018 Jun;70(6):363-372. doi: 10.1007/s00251-017-1047-x. Epub 2017 Dec 1.

PMID:
29196796
38.

Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation.

den Dulk AC, Shi X, Verhoeven CJ, Dubbeld J, Claas FHJ, Wolterbeek R, Brand-Schaaf SH, Verspaget HW, Sarasqueta AF, van der Laan LJW, Metselaar HJ, van Hoek B, Kwekkeboom J, Roelen DL.

Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13163. Epub 2017 Dec 23.

PMID:
29193362
39.

The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.

van den Heuvel H, Heutinck KM, van der Meer-Prins EMW, Franke-van Dijk MEI, van Miert PPMC, Zhang X, Ten Berge IJM, Claas FHJ.

Hum Immunol. 2018 Jan;79(1):39-50. doi: 10.1016/j.humimm.2017.10.019. Epub 2017 Oct 31.

PMID:
29100943
40.

Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization.

Saris A, Tomson B, Brand A, Mulder A, Claas FH, Lorinser J, Scharenberg J, van Ham SM, Ten Brinke A, Zwaginga JJ, van der Meer PF.

Blood. 2018 Jan 4;131(1):144-152. doi: 10.1182/blood-2017-07-799270. Epub 2017 Nov 1.

41.

Novel aspects of epitope matching and practical application in kidney transplantation.

Lim WH, Wong G, Heidt S, Claas FHJ.

Kidney Int. 2018 Feb;93(2):314-324. doi: 10.1016/j.kint.2017.08.008. Epub 2017 Oct 20. Review.

PMID:
29061333
42.

Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.

Heidt S, Haasnoot GW, van Rood JJ, Witvliet MD, Claas FHJ.

Kidney Int. 2018 Feb;93(2):491-500. doi: 10.1016/j.kint.2017.07.018. Epub 2017 Sep 22.

PMID:
28947279
43.

The Humoral Theory of Transplantation.

Ravindranath MH, Cai J, Ferrone S, Claas FHJ, Selvan SR.

J Immunol Res. 2017;2017:5935123. doi: 10.1155/2017/5935123. Epub 2017 Aug 8. No abstract available.

44.

KIR2DS2 recognizes conserved peptides derived from viral helicases in the context of HLA-C.

Naiyer MM, Cassidy SA, Magri A, Cowton V, Chen K, Mansour S, Kranidioti H, Mbiribindi B, Rettman P, Harris S, Fanning LJ, Mulder A, Claas FHJ, Davidson AD, Patel AH, Purbhoo MA, Khakoo SI.

Sci Immunol. 2017 Sep 15;2(15). pii: eaal5296. doi: 10.1126/sciimmunol.aal5296.

PMID:
28916719
45.

The seed to success: The role of seminal plasma in pregnancy.

Nederlof I, Meuleman T, van der Hoorn MLP, Claas FHJ, Eikmans M.

J Reprod Immunol. 2017 Sep;123:24-28. doi: 10.1016/j.jri.2017.08.008. Epub 2017 Aug 24. Review.

PMID:
28886486
46.

Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation.

van de Weijer ML, Schuren ABC, van den Boomen DJH, Mulder A, Claas FHJ, Lehner PJ, Lebbink RJ, Wiertz EJHJ.

J Cell Sci. 2017 Sep 1;130(17):2883-2892. doi: 10.1242/jcs.206839. Epub 2017 Jul 25.

47.

Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.

D'Orsogna L, van den Heuvel H, van Kooten C, Heidt S, Claas FHJ.

Immunogenetics. 2017 Aug;69(8-9):631-641. doi: 10.1007/s00251-017-0989-3. Epub 2017 Jul 17. Review.

48.

Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.

Murray SE, Nesterenko PA, Vanarsdall AL, Munks MW, Smart SM, Veziroglu EM, Sagario LC, Lee R, Claas FHJ, Doxiadis IIN, McVoy MA, Adler SP, Hill AB.

J Exp Med. 2017 Jul 3;214(7):1889-1899. doi: 10.1084/jem.20161988. Epub 2017 May 31.

49.

When selecting a cord blood unit from a firstborn donor verify that the patient shares an Ag with the unit that is foreign to the mother of the donor.

van Rood JJ, Brand A, Scaradavou A, Claas FH, Oudshoorn M, Stevens CE.

Bone Marrow Transplant. 2017 Jul;52(7):1039-1040. doi: 10.1038/bmt.2017.75. Epub 2017 Apr 24. No abstract available.

PMID:
28436971
50.

Defining the immunogenicity and antigenicity of HLA epitopes is crucial for optimal epitope matching in clinical renal transplantation.

Kramer CSM, Roelen DL, Heidt S, Claas FHJ.

HLA. 2017 Jul;90(1):5-16. doi: 10.1111/tan.13038. Epub 2017 Apr 5. Review.

PMID:
28378521

Supplemental Content

Loading ...
Support Center